Drug intelligence / Profile preview

5-hydroxymethylfurfural

Development stage
Discontinued
Modality
Small Molecules
Administration
Oral
01

Overview

5-hydroxymethylfurfural (HMF) is an organic compound formed by the dehydration of reducing sugars and is commonly found in heat-treated foods. It consists of a furan ring with both aldehyde and alcohol functional groups. HMF has been investigated as a small molecule drug, particularly under the code name AES-103, for its potential to treat sickle cell disease by binding intracellular sickle hemoglobin (HbS) and inhibiting the formation of sickled cells. Preclinical studies have shown that orally administered HMF can reduce sickling in transgenic mouse models. Additionally, it has demonstrated anti-inflammatory effects by suppressing the NF-kB/NLRP3 inflammasome cascade through attenuation of ER stress in cellular and animal models[4][6]. Its primary indications studied include hypoxia, anemia, and sickle cell disease[2][3][4]. HMF is also widely used as a food additive and flavoring agent but its pharmaceutical development for sickle cell disease appears to have been discontinued after phase II trials[3].

Other names
5-(hydroxymethyl)-2-furaldehyde5-(Hydroxymethyl)-2-furfural5-(Hydroxymethyl)furfural5-HydroxymethylfurfuralHydroxymethylfurfural

Beyond the preview

Go deeper on 5-hydroxymethylfurfural.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5-hydroxymethylfurfural.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call